Ascending to improve treatment options, outcomes, and lives

Clinical Trials

Ascendis Pharma is committed to developing its own proprietary pipeline of unique products that meet unmet patient needs.

We have initiated the Phase 3 heiGHt Trial to evaluate daily TransCon Growth Hormone in children with GHD. To learn more about the phase 3 heiGHt Trial and receive future information, please visit:

Phase 3 heiGHt Trial Initiated

Our phase 3 clinical trial for TransCon Growth Hormone — the heiGHt Trial – has been initiated.